India's Natco Pharma Eyes Several Other Generics For CL Applications
This article was originally published in PharmAsia News
Executive Summary
India's precedent-setting drug maker Natco Pharma, which received the nation's first compulsory license to market a generic, is set to use the license for many more generic drug versions, its chief says.